ARICI MARTINA

Arici, M., Hsu, S., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., et al. (2024). Selective SERCA2a activator as a candidate for chronic heart failure therapy. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-04874-9]. Detail

(2023). Selective SERCA2a stimulation: a new promising therapeutic approach for heart failure treatment. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2023). Detail

Altomare, C., Bartolucci, C., Sala, L., Balbi, C., Burrello, J., Pietrogiovanna, N., et al. (2023). A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes. COMMUNICATIONS BIOLOGY, 6(1) [10.1038/s42003-023-04674-9]. Detail

Arici, M., Ferrandi, M., Barassi, P., Hsu, S., Torre, E., Luraghi, A., et al. (2023). Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 384(1), 231-244 [10.1124/jpet.122.001335]. Detail

Luraghi, A., Ferrandi, M., Barassi, P., Arici, M., Hsu, S., Torre, E., et al. (2022). Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure. JOURNAL OF MEDICINAL CHEMISTRY, 65(10), 7324-7333 [10.1021/acs.jmedchem.2c00347]. Detail